1. Identification of targets of JS-K against HBV-positive human hepatocellular carcinoma HepG2.2.15 cells with iTRAQ proteomics
   Zhengyun Liu et al, 2021, Scientific Reports CrossRef
2. MiR-876-5p acts as an inhibitor in hepatocellular carcinoma progression by targeting DNMT3A
   Yizhou Wang et al, 2018, Pathology - Research and Practice CrossRef